The Protective Effect of Smilax Glabra Extract on Advanced Glycation End Products-Induced Endothelial Dysfunction in HUVECs Via RAGE-ERK1/2-NF-κB Pathway.

Hai-qiang Sang,Jun-fei Gu,Jia-rui Yuan,Ming-hua Zhang,Xiao-bin Jia,Liang Feng
DOI: https://doi.org/10.1016/j.jep.2014.06.028
IF: 5.195
2014-01-01
Journal of Ethnopharmacology
Abstract:Ethnopharmacological relevance: Smilax glabra Roxb. (SGR) is a traditional Chinese herb that has been used in folk for the treatment of diabetic vascular complications. Advanced glycation end products (AGEs)-induced endothelial dysfunction has been thought to be a major cause of diabetic vascular complications. The present study was conducted to investigate the protective effect of SGR extract on AGEs-induced endothelial dysfunction and its underlying mechanisms.Materials and methods: Human umbilical vein endothelial cells (HUVECs) were exposed to 200 mu g/ml AGEs to induce endothelial dysfunction. Acridine orange/ethidium bromide (AO/EB) fluorescence assay and Annexin-V/PI double-staining were performed to determine endothelium apoptosis. Dihydroethidium (DHE) fluorescence probe, SOD and MDA kits were used to evaluate oxidative stress. The effect of SGR extract on AGEs-induced TGF-beta1 expression was determined by immunocytochemistry and western blotting. Attenuations of SGR extract on receptor for AGEs (RAGE) expression, extracellular regulated protein kinases (ERK1/2) activation and NF-kappa B phosphorylation were determined by immunofluorescence assay and western blotting. The blockade assays for RAGE and ERK1/2 were carried out using a specific RAGE-antibody (RAGE-Ab) or a selective ERK1/2 inhibitor PD98059 in immunofluorescence assay.Results: The pretreatment of SGR extract (0.125, 0.25 and 0.5 mg crude drug/ml) significantly attenuated AGEs-induced endothelium apoptosis, and down-regulated TGF-beta1 protein expression in HUVECs. It was also well shown that SGR extract could down-regulate dose-dependently ROS over-generation, MDA content, TGF-beta1 expression, ERK1/2 and NF-kappa B activation whereas increase significantly SOD activity. Furthermore, the AGEs-induced ERK1/2 activation could be attenuated by the blockade of RAGE-Ab (5 mu g/ml) while the NF-kappa B activation was ameliorated by ERK1/2 inhibitor PD98059 (10 mu M).Conclusion: These results indicated that SGR extract could attenuate AGEs-induced endothelial dysfunction via RAGE-ERK1/2-NF-kappa B pathways. Our findings suggest that SGR extract may be beneficial for attenuating endothelial dysfunction in diabetic vascular complications. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
What problem does this paper attempt to address?